No abstract available
Publication types
-
Clinical Trial
-
Clinical Trial, Phase II
-
Letter
MeSH terms
-
Angiogenesis Inhibitors / adverse effects*
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cisplatin / administration & dosage
-
Cyclophosphamide / administration & dosage
-
Dexamethasone / administration & dosage
-
Doxorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Humans
-
Lymphoma, Mantle-Cell / drug therapy
-
Multiple Myeloma / drug therapy*
-
Prednisone / administration & dosage
-
Rituximab
-
Thalidomide / adverse effects*
-
Thromboembolism / chemically induced*
-
Thromboembolism / drug therapy
-
Vincristine / administration & dosage
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Rituximab
-
Thalidomide
-
Vincristine
-
Etoposide
-
Dexamethasone
-
Doxorubicin
-
Cyclophosphamide
-
Cisplatin
-
Prednisone